![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 28, 25281-25284, July 11, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCELERATED PUBLICATIONS
(PPAR
)-interacting Protein, Is Required for PPAR
-mediated Adipogenesis*

From the Department of Pathology, Northwestern University, The Feinberg School of Medicine, Chicago, Illinois 60611-3008
Nuclear receptor coactivator PRIP (peroxisome proliferators-activated
receptor (PPAR
)-interacting protein) appears to serve as a linker
between cAMP response element-binding protein-binding protein
(CBP/p300)anchored and PBP (PPAR
-binding protein)-anchored coactivator
complexes involved in the transcriptional activity of nuclear receptors.
Disruption of PRIP and PBP genes results in embryonic lethality between
embryonic day 11.5 and 12.5 (postcoitum), indicating that PRIP and PBP are
essential and nonredundant coactivators. Both PRIP and PBP were initially
identified as PPAR
coactivators, suggesting a role for these molecules
in PPAR
-induced adipogenesis.
PBP/ mouse embryonic
fibroblasts fail to exhibit PPAR
-stimulated adipogenesis indicating
that PBP is a downstream regulator of PPAR
-mediated adipogenesis. We
now show that PRIP/ mouse
embryonic fibroblasts are also refractory to PPAR
-stimulated
adipogenesis and fail to express adipogenic marker aP2, a
PPAR
-responsive gene. Chromatin immunoprecipitation assays reveal
reduced association in PRIP/
cells of PIMT (PRIP-binding protein) and PBP with aP2 gene promoter,
suggesting that PRIP is required for the linking of CBP/p300-anchored cofactor
complex with PBP-anchored mediator complex. These data indicate that PRIP,
like PBP, is a downstream regulator of PPAR
-mediated adipogenesis and
that both these coactivators are required for the successful completion of
adipogenic program.
Received for publication, April 23, 2003
* This work was supported by National Institutes of Health Grants GM23750 (to J. K. R.), CA84472 (to M. S. R.), and CA64239 and K08 ES00356 (to Y.-J. Z.) and by the Joseph L. Mayberry Sr. Endowment Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology, Northwestern
University, Feinberg School of Medicine, 303 East Chicago Ave., Chicago, IL
60611-3008. Tel.: 312-503-8144; Fax: 312-503-8249; E-mail:
jkreddy{at}northwestern.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Surapureddi, R. Rana, J. K. Reddy, and J. A. Goldstein Nuclear Receptor Coactivator 6 Mediates the Synergistic Activation of Human Cytochrome P-450 2C9 by the Constitutive Androstane Receptor and Hepatic Nuclear Factor-4{alpha} Mol. Pharmacol., September 1, 2008; 74(3): 913 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ge, Y.-W. Cho, H. Guo, T. B. Hong, M. Guermah, M. Ito, H. Yu, M. Kalkum, and R. G. Roeder Alternative Mechanisms by Which Mediator Subunit MED1/TRAP220 Regulates Peroxisome Proliferator-Activated Receptor {gamma}-Stimulated Adipogenesis and Target Gene Expression Mol. Cell. Biol., February 1, 2008; 28(3): 1081 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, L. Qiang, and S. R. Farmer Identification of a Domain within Peroxisome Proliferator-Activated Receptor {gamma} Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes Mol. Cell. Biol., January 1, 2008; 28(1): 188 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, Q. Kang, and D.-M. Wang Constitutive Coactivator of Peroxisome Proliferator-Activated Receptor (PPAR{gamma}), a Novel Coactivator of PPAR{gamma} that Promotes Adipogenesis Mol. Endocrinol., October 1, 2007; 21(10): 2320 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors Pharmacol. Rev., December 1, 2006; 58(4): 726 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujimura, C. Kimura, T. Oe, Y. Takata, H. Sakuma, I. Aramori, and S. Mutoh A Selective Peroxisome Proliferator-Activated Receptor {gamma} Modulator with Distinct Fat Cell Regulation Properties J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mahajan and H. H. Samuels Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development Endocr. Rev., June 1, 2005; 26(4): 583 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jia, C. Qi, P. Kashireddi, S. Surapureddi, Y.-J. Zhu, M. S. Rao, D. Le Roith, P. Chambon, F. J. Gonzalez, and J. K. Reddy Transcription Coactivator PBP, the Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein, Is Required for PPAR{alpha}-regulated Gene Expression in Liver J. Biol. Chem., June 4, 2004; 279(23): 24427 - 24434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Reddy Peroxisome Proliferators and Peroxisome Proliferator-Activated Receptor {alpha}: Biotic and Xenobiotic Sensing Am. J. Pathol., June 1, 2004; 164(6): 2305 - 2321. [Full Text] [PDF] |
||||
![]() |
S. Cheng, H. Afif, J. Martel-Pelletier, J.-P. Pelletier, X. Li, K. Farrajota, M. Lavigne, and H. Fahmi Activation of Peroxisome Proliferator-activated Receptor {gamma} Inhibits Interleukin-1{beta}-induced Membrane-associated Prostaglandin E2 Synthase-1 Expression in Human Synovial Fibroblasts by Interfering with Egr-1 J. Biol. Chem., May 21, 2004; 279(21): 22057 - 22065. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |